These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21965338)

  • 61. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
    Demeulemeester J; Kumar P; Møller EK; Nord S; Wedge DC; Peterson A; Mathiesen RR; Fjelldal R; Zamani Esteki M; Theunis K; Fernandez Gallardo E; Grundstad AJ; Borgen E; Baumbusch LO; Børresen-Dale AL; White KP; Kristensen VN; Van Loo P; Voet T; Naume B
    Genome Biol; 2016 Dec; 17(1):250. PubMed ID: 27931250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.
    Győrffy B; Pongor L; Bottai G; Li X; Budczies J; Szabó A; Hatzis C; Pusztai L; Santarpia L
    Br J Cancer; 2018 Apr; 118(8):1107-1114. PubMed ID: 29559730
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mitochondrial DNA mutations in Malaysian female breast cancer patients.
    Omasanggar R; Yu CY; Ang GY; Emran NA; Kitan N; Baghawi A; Falparado Ahmad A; Abdullah MA; Teh LK; Maniam S
    PLoS One; 2020; 15(5):e0233461. PubMed ID: 32442190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E
    PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Next-generation sequencing.
    Reis-Filho JS
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S12. PubMed ID: 20030863
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.
    Roukos DH
    Pharmacogenomics J; 2011 Apr; 11(2):81-92. PubMed ID: 20975737
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
    Lin PH; Kuo WH; Huang AC; Lu YS; Lin CH; Kuo SH; Wang MY; Liu CY; Cheng FT; Yeh MH; Li HY; Yang YH; Hsu YH; Fan SC; Li LY; Yu SL; Chang KJ; Chen PL; Ni YH; Huang CS
    Oncotarget; 2016 Feb; 7(7):8310-20. PubMed ID: 26824983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
    Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
    Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood.
    Gyanchandani R; Kvam E; Heller R; Finehout E; Smith N; Kota K; Nelson JR; Griffin W; Puhalla S; Brufsky AM; Davidson NE; Lee AV
    Sci Rep; 2018 Nov; 8(1):17313. PubMed ID: 30470782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
    Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
    Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Personalized therapy for breast cancer.
    De Abreu FB; Schwartz GN; Wells WA; Tsongalis GJ
    Clin Genet; 2014 Jul; 86(1):62-7. PubMed ID: 24635704
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular classification of breast cancer: what the pathologist needs to know.
    Rakha EA; Green AR
    Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.
    Gerratana L; Davis AA; Shah AN; Lin C; Corvaja C; Cristofanilli M
    Curr Treat Options Oncol; 2019 Jun; 20(8):68. PubMed ID: 31256282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Precision medicine in breast cancer.
    Naito Y; Urasaki T
    Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating Plasma Tumor DNA.
    Parsons HA; Beaver JA; Park BH
    Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances for studying clonal evolution in cancer.
    Ding L; Raphael BJ; Chen F; Wendl MC
    Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Genomic basis for breast cancer: advances in personalized medicine].
    Hidalgo-Miranda A; Jiménez-Sánchez G
    Salud Publica Mex; 2009; 51 Suppl 2():s197-207. PubMed ID: 19967275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. EMu: probabilistic inference of mutational processes and their localization in the cancer genome.
    Fischer A; Illingworth CJ; Campbell PJ; Mustonen V
    Genome Biol; 2013 Apr; 14(4):R39. PubMed ID: 23628380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.